Genome Engineering Market To Reach USD 30.9 Billion by 2032, Growing at CAGR 16.7% | Agilent Technologies, Bluebird Bio, Boehringer Ingelheim

Yahoo FinanceFeb 12 07:24 ET

Lacklustre Performance Is Driving Bluebird Bio, Inc.'s (NASDAQ:BLUE) 30% Price Drop

Simply Wall StFeb 6 05:18 ET

Bluebird Bio Price Target Lowered to $8 at RBC Capital on 'Limited Cash Runway'

TipRanksJan 7 08:46 ET

RBC Adjusts Price Target on Bluebird Bio to $8 From $80 Amid Reverse Stock Split, 'Limited Cash Runway,' Keeps Sector Perform, Speculative Risk

MT NewswiresJan 7 07:38 ET · Ratings

Analysts Offer Insights on Healthcare Companies: Cencora (COR) and Bluebird Bio (BLUE)

TipRanksJan 7 05:40 ET · Ratings

Express News | Bluebird bio Inc : Leerink Partners Raises Target Price to $10 From $1

ReutersJan 2 22:43 ET